Advertisement
News
Advertisement

Synovex gets $3.5M fundraise, plans clinical trials

Thu, 10/11/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Cambridge biotech Synovex Corp., which plans to begin clinical trials this year with a potential treatment for rheumatoid arthritis and fibrotic diseases, has raised the first half of a $7 million round, according to federal filings.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading